Ekso Bionics Holdings Inc
F:23E2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Ekso Bionics Holdings Inc
F:23E2
|
US |
|
M3 Inc
TSE:2413
|
JP |
|
Goosehead Insurance Inc
NASDAQ:GSHD
|
US |
|
Ki Group Holding SpA
MIL:KI
|
IT |
|
eGain Corp
NASDAQ:EGAN
|
US |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
Bolsa Mexicana de Valores SAB de CV
BMV:BOLSAA
|
MX |
|
JD Sports Fashion PLC
LSE:JD
|
UK |
|
Third Coast Bancshares Inc
NYSE:TCBX
|
US |
|
I
|
Intel Corp
DUS:INL
|
US |
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Darma Henwa Tbk PT
IDX:DEWA
|
ID |
|
P
|
PCBL Ltd
BSE:506590
|
IN |
|
Applovin Corp
NASDAQ:APP
|
US |
|
M
|
MultiChoice Group Ltd
JSE:MCG
|
ZA |
|
Applied DNA Sciences Inc
NASDAQ:BNBX
|
US |
|
Intertrust NV
F:4IT
|
NL |
|
N
|
Nextera Energy Inc
SWB:FP3
|
US |
|
Metro Bank PLC
LSE:MTRO
|
UK |
|
Chemed Corp
NYSE:CHE
|
US |
|
Wall Financial Corp
TSX:WFC
|
CA |
|
B
|
BNP Paribas SA
OTC:BNPQF
|
FR |
|
Hercules Capital Inc
LSE:0J4M
|
US |
|
Saia Inc
NASDAQ:SAIA
|
US |
DCF Value
This DCF valuation model was created by
Alpha Spread
and was last updated on Jun 3, 2026.
Estimated DCF Value of one
23E2
stock is
hidden
EUR.
Compared to the current market price of 3.315 EUR, the stock is
hidden
.
Present Value Calculation
This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.
DCF Model
Base Case Scenario
Switching the operating model will discard any changes made to the current valuation.
DCF Model
DCF Value Calculation
This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.
Present Value to DCF Value
Capital Structure
DCF Capital Structure
Valuation Analysis
Sensitivity Analysis
DCF Value Sensitivity Analysis
Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.
DCF Sensitivity Analysis
DCF Financials
Financials used in DCF Calculation
DCF Financials
What is the DCF value of one 23E2 stock?
Estimated DCF Value of one
23E2
stock is
hidden
EUR.
Compared to the current market price of 3.315 EUR, the stock is
hidden
.
The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.
How was the DCF Value calculated?
1. Present Value Calculation.
Utilizing the DCF operating model, Ekso Bionics Holdings Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at
hidden
.
2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of hidden per share.
